Clinical Trial Update: Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial update on paclitaxel-albumin bound with carboplatin for ovarian cancer report focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN